3rd Istanbul Immunohematology Summit
21 May, 2021
22 May, 2021

 

TIME HALL A HALL B
13:30 – 13:45 Opening Ceremony
Speakers: Güner Hayri Özsan (Dokuz Eylül University, Turkey), Muhlis Cem Ar (İstanbul University -Cerrahpaşa, Turkey), Şule Ünal Cangül (Hacettepe University, Turkey), Meltem Kurt Yüksel (Ankara University, Turkey), Reyhan Küçükkaya (Turkey), Neslihan Andıç (Eskişehir Osmangazi University, Turkey), Leylagül Kaynar (Erciyes University, Turkey)
13:45 – 14:00 Break
14:00-15:30 MULTIPLE MYELOMA PEDIATRIC  LEUKEMIAS-I
Scientific Chair: Ömür Gökmen Sevindik (Medipol University, Turkey), Pieter Sonneveld (Erasmus MC, Netherlands) 
Antibodies Upfront or at Relapse?: Pieter Sonneveld (Erasmus MC, Netherlands)
What is the Best Treatment Sequence for RRMM?: Thierry Facon (Lille University Hospital, France)
Is MRD the New Outcome in Clinical Practice?: Francesca Gay (City of Health and Science University Hospital of Turin, Italy)

Scientific Chair:  Hale Ören (Dokuz Eylül University, Turkey), Michael Dworzak (St. Anna Children’s Hospital, Austria)

Advancements of the I-BFM FLOW Network: Innovative Solutions for Diagnosis and MRD Assessment in Acute Leukemias: Michael Dworzak (St. Anna Children’s Hospital, Austria)

FLOW-MRD in the Era of BITE & CART Therapies: Alexander Popov (Federal Research and Clinical Centre, Russia)

 Towards shaping a high-quality network of FLOW-MRD labs in Turkey: Günnur Deniz (Istanbul University, Turkey)
15:30 – 16:00 Break
16:00 – 16:45

SATELLITE SYMPOSIUM

New Dimension in Efficacy: Darzalex in RRMM

Scientific Chair: Meral Beksaç (Ankara University, Turkey)
Speakers: Erdal Kurtoğlu (Antalya Training and Research Hospital, Turkey), Ömür Gökmen Sevindik (Medipol University, Turkey)
16:45 – 17:15 Break
17:15 – 18:45 CHRONIC MYELOID LEUKEMIA PEDIATRIC LEUKEMIAS-II

Scientific Chair: Ahmet Emre Eşkazan (İstanbul University -Cerrahpaşa, Turkey), Susanne Saussele (University Hospital Mannheim, Germany) 

Modern CML Treatment According to the New ELN Recommendations: Mario Tiribelli (University of Udine, Italy)

Treatment Free Remission. A Goal for All CML Patients?: Susanne Saussele (University Hospital Mannheim, Germany)

New Options for Patients After 1st Line: Ahmet Emre Eşkazan (İstanbul University -Cerrahpaşa, Turkey)

Scientific Chair: Volkan Hazar (Medstar Hospital, Turkey), Fatih Okcu (Texas Children’s Hospital, USA)

Epidemiology of Late Effects in Children with Acute Lymphoblastic Leukemia: Fatih Okcu (Texas Children’s Hospital, USA)

Obesity and Metabolic Syndrome in Childhood Acute Lymphoblastic Leukemia Survivors: Kala Kamdar (Texas Children’s Hospital, USA)

Early Aging, Chronic Conditions and Biological Indicators of Aging in Childhood Acute Lymphoblastic Leukemia Survivors: Monica Gramatges (Texas Children’s Hospital, USA)
 18:45 – 19:15 Break
19:15 – 20:45 INDOLENT LYMPHOMAS
Scientific Chair: Meltem Olga Akay ( Koç University , Turkey), Eva Kimby (Karolinska Institute, Sweden)
Follicular Lymphoma with Focus on Therapy: Eva Kimby (Karolinska Institute, Sweden)
Cellular Therapies for Follicular Lymphoma: Koen Van Besien (Presbyterian Hospital, USA)                                             Management of Marginal Zone Lymphoma: Catherine Thieblemont (Hôpital Saint-Louis, France)
20:45 – 21:00 Break
21:00-21:45

SATELLITE SYMPOSIUM

Carfilzomib Treatment in Relapsed/Refractory Multiple Myeloma

Scientific Chair: Tülin Tuğlular (Marmara University, Turkey)
Speaker: Joseph Mikhael (Translational Genomic Research Institute, USA)
21:45 – 22:00 Break
22:00 – 23:00 ORAL PRESENTATIONS